Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. - Wikidata - awgldk - TriplyDB

Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study.

Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study.

http://www.wikidata.org/entity/Q34268116

about

Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia Future challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSA Mannose-binding lectin-deficient mice are susceptible to infection with Staphylococcus aureus Effectiveness of a bundled intervention of decolonization and prophylaxis to decrease Gram positive surgical site infections after cardiac or orthopedic surgery: systematic review and meta-analysis Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications Dalbavancin in the treatment of complicated skin and soft-tissue infections: a review Improving Clinical Outcomes in Patients With Methicillin-Sensitive Staphylococcus aureus Bacteremia and Reported Penicillin Allergy Mechanisms of resistance and clinical relevance of resistance to β-lactams, glycopeptides, and fluoroquinolones Potential role for telavancin in bacteremic infections due to gram-positive pathogens: focus on Staphylococcus aureus Cationic antimicrobial peptide LL-37 is effective against both extra- and intracellular Staphylococcus aureus Synergy between vancomycin and nafcillin against Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model Empiric antibiotic therapy for Staphylococcus aureus bacteremia may not reduce in-hospital mortality: a retrospective cohort study Acute bacterial skin and skin structure infections in internal medicine wards: old and new drugs.Is methicillin-resistant Staphylococcus aureus replacing methicillin-susceptible S. aureus?Treatment duration for uncomplicated Staphylococcus aureus bacteremia to prevent relapse: analysis of a prospective observational cohort study.Early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection (SABATO): study protocol for a randomized controlled trial.Thrombocytopaenia during methicillin-sensitive Staphylococcus aureus bacteraemia.Epidemiology of community-onset Staphylococcus aureus infections in pediatric patients: an experience at a Children's Hospital in central Illinois.Rapid identification of bacteria from positive blood culture bottles by use of matrix-assisted laser desorption-ionization time of flight mass spectrometry fingerprinting Characteristics of invasive Staphylococcus aureus infections in three regions of Korea, 2009-2011: a multi-center cohort study Cephalosporin-Glycopeptide Combinations for Use against Clinical Methicillin-Resistant Staphylococcus aureus Isolates: Enhanced In vitro Antibacterial Activity.Real-time PCR testing for mecA reduces vancomycin usage and length of hospitalization for patients infected with methicillin-sensitive staphylococci.A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study.Clinical and Microbiological Determinants of Outcome in Staphylococcus aureus Bacteraemia Tolerability of cefazolin after immune-mediated hypersensitivity reactions to nafcillin in the outpatient setting.Intra- and extracellular activities of dicloxacillin against Staphylococcus aureus in vivo and in vitro.Establishment of a superficial skin infection model in mice by using Staphylococcus aureus and Streptococcus pyogenes Outcomes with daptomycin in the treatment of Staphylococcus aureus infections with a range of vancomycin MICs.Determinants of methicillin-susceptible Staphylococcus aureus native bone and joint infection treatment failure: a retrospective cohort study Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.Clinical management of Staphylococcus aureus bacteremia: a review.The role of vancomycin in the persistence or recurrence of Staphylococcus aureus bacteraemia.Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.Staphylococcus aureus infection induces protein A-mediated immune evasion in humans.Intra- and extracellular activities of dicloxacillin and linezolid against a clinical Staphylococcus aureus strain with a small-colony-variant phenotype in an in vitro model of THP-1 macrophages and an in vivo mouse peritonitis model.Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia Genetic and molecular predictors of high vancomycin MIC in Staphylococcus aureus bacteremia isolates.Reversible antibiotic tolerance induced in Staphylococcus aureus by concurrent drug exposure.High cell-free DNA predicts fatal outcome among Staphylococcus aureus bacteraemia patients with intensive care unit treatment.Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial.

P2860

Q21261829-11CC6271-8FCB-482C-AC35-EAE19CA55D7F Q22305769-6A2E566A-1D72-46E0-88C1-2CD74029DF14 Q24293487-9CFB867D-7E76-44CB-B96D-1B6E74D65F4F Q24613157-D813DE6A-7096-4F42-A266-B70FC025B237 Q24646677-E4395D99-1C1E-4285-A6CC-254484CF8F91 Q24647429-B234AD6F-34DA-459A-AB63-4325A9116DF6 Q26779453-63A6D473-F298-4E6B-B992-2A6042FADE0F Q26828604-2D128E23-552B-475C-9A51-651C11719AFB Q27027412-A4361880-EFF0-4DAC-8AA5-430965BDF71E Q28395363-ED5E4624-8EC8-4334-B142-69FD20CA09F4 Q28481497-11D72CF5-B41E-4157-9635-3453FB2E820D Q28750538-34545DDB-2DDC-47A4-8A40-D4DC790AF8AE Q30251580-C7065194-764E-415B-9C0E-5447B1A0FFCD Q30424717-6A5800A5-0E5F-44D8-8145-882BBEEEEA90 Q30449846-6EC277BC-FE0D-4F48-AE0E-5B9B915D652C Q30667465-A814AFEF-1765-4986-B56C-81E46F10C4CA Q33437851-90D5D261-A0A7-4984-B433-6B3758BFB365 Q33483064-40300F80-B7DE-4BC5-AC5A-E57DBD96B3B8 Q33541809-2AC4B1CC-6FCA-4F17-9946-54392872766D Q33644439-455400F4-19F6-41B3-82D8-06821E5B42E1 Q33700986-C30B3D0E-73E8-4ECA-98DE-3789B656BFF1 Q33704733-34927BC7-BF22-42A3-8209-E1E64A7574BC Q33723124-E0A187D3-4CFC-4A17-8F19-AFE27CE945F7 Q33734119-7F410111-1524-46BB-B30C-1FAFE74E3103 Q33797925-F7842AAB-1424-4408-85F5-E43FF7C54DD5 Q33876454-3E281283-BCD4-4C07-A90A-BDB521F1E19E Q33938185-51ACAC98-F76B-4640-A3CE-895509A171A1 Q33997671-D5641C7E-FD7C-4A4B-B5A5-954FD1AB36B2 Q34100226-668E34A1-8EA3-42AE-99D7-019B4573D359 Q34157657-92ED2FCF-36C4-4F4B-8F37-6A07F3801EC1 Q34441035-F58A5696-44D2-4268-BE21-582CB6BC0732 Q34447860-B090B198-C3D5-4764-8E45-464DC3DCF86B Q34478074-585DBC1A-9305-4FC4-904E-89B1F83DF9F4 Q34533083-A4EEDDA9-7E93-498C-9F86-5FEC85855067 Q34737534-B1B5ADEA-5534-4B05-8D8A-29EC29137C65 Q34973729-C3737788-9A9B-40AF-B23D-E5F41BDD73E2 Q35035799-B30EBDF1-D5E9-4AE7-A7AB-D818431A9324 Q35038242-299B4A15-7C40-4B0A-B5C5-EFEF25966189 Q35092654-45C7CBA9-9E8E-492A-A136-786117FEB2D1 Q35179800-54DF35BE-72DC-498E-97FF-5F17F8F7BE27

P2860

Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study.

http://www.wikidata.org/entity/Q34268116

description

2003 nî lūn-bûn

@nan

2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Staphylococcus aureus bacterem ...... prospective multicenter study.

@ast

Staphylococcus aureus bacterem ...... prospective multicenter study.

@en

Staphylococcus aureus bacterem ...... prospective multicenter study.

@nl

type

label

Staphylococcus aureus bacterem ...... prospective multicenter study.

@ast

Staphylococcus aureus bacterem ...... prospective multicenter study.

@en

Staphylococcus aureus bacterem ...... prospective multicenter study.

@nl

prefLabel

Staphylococcus aureus bacterem ...... prospective multicenter study.

@ast

Staphylococcus aureus bacterem ...... prospective multicenter study.

@en

Staphylococcus aureus bacterem ...... prospective multicenter study.

@nl

P1433

Q34268116-6B48574D-0F09-4906-B200-A870869E3B62

P1476

Q34268116-AAEF073F-9187-4224-A80D-11FDBAF2F8D9

P2093

Q34268116-005A16F1-6FC8-4A0C-8798-F1EADC260921

Q34268116-0DF4B3BC-F9F7-46E7-8504-0370F7BBEC32

Q34268116-10186FD4-6DC6-4B44-AA89-B6D2A2B134D7

Q34268116-124FE043-FD66-4D88-897C-E2E5B82091B2

Q34268116-19F5D5A0-856D-4E6D-9B78-DDFC6C36EA8F

Q34268116-32B7FB89-9B0E-4DB3-A360-917B9428A382

Q34268116-3EB890E9-262D-42DB-A6F5-6779C8850F21

Q34268116-AD3E383E-A339-4A71-A4C4-9ACC892FCB66

Q34268116-E87951C2-FF70-4B01-8B6E-33FCF9C3A346

P304

Q34268116-8037B98E-6CC9-40D6-8531-136DC5DC975A

P31

Q34268116-4DBFC914-0133-4CAE-B72E-1DBE5C813A8D

P356

Q34268116-E0DDBF77-250C-4B4A-A0D8-24B05FA7016C

P407

Q34268116-540F9060-CC24-498B-AF2B-46FEE0AF81F4

P433

Q34268116-DC6A93FB-3667-4E4A-BBB4-9A866BA4C66A

P478

Q34268116-1EC9D076-1C14-43F9-B650-CDB925D3F5F4

P577

Q34268116-9320A7DB-727E-46BA-8DEE-F27D353DD2A1

P5875

Q34268116-B22606E6-7489-4684-BAF4-44261127F75B

P698

Q34268116-52AE3B52-4722-42F6-B713-9A95B71F1B3C

P921

Q34268116-10B25938-7AA5-41D8-87FC-8404890F31E9

Q34268116-AFBDC2B2-E563-4FA2-8DCA-86053A871E4E

P356

01.MD.0000091184.93122.09

P1433

P1476

Staphylococcus aureus bacterem ...... prospective multicenter study.

@en

P2093

Alice O'Donnell

http://www.w3.org/2001/XMLSchema#string

Brent B MacDonald

http://www.w3.org/2001/XMLSchema#string

Daniel M Musher

http://www.w3.org/2001/XMLSchema#string

Feng-Yee Chang

http://www.w3.org/2001/XMLSchema#string

James E Peacock

http://www.w3.org/2001/XMLSchema#string

Joseph M Mylotte

http://www.w3.org/2001/XMLSchema#string

Marilyn M Wagener

http://www.w3.org/2001/XMLSchema#string

Patricia Triplett

http://www.w3.org/2001/XMLSchema#string

Victor L Yu

http://www.w3.org/2001/XMLSchema#string

P304

333-339

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/01.MD.0000091184.93122.09

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

82

http://www.w3.org/2001/XMLSchema#string

P577

2003-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

9061546

http://www.w3.org/2001/XMLSchema#string

P698

14530782

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial